ANARGYROS SKALIOTIS: Open Payments
NPI 1265491807 · NORTH DARTMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$858 in 37 payments from 14 companies in 2025. Trend: 2023 $1,846 · 2024 $1,929 · 2025 $858
Food & beverage: $858
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $461 |
| Electromed, Inc. | 4 | $77 |
| Viatris Specialty LLC | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Grifols USA, LLC | 1 | $35 |
| Verona Pharma, Inc. | 1 | $31 |
| United Therapeutics Corporation | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Genentech USA, Inc. | 1 | $23 |
| GENZYME CORPORATION | 1 | $23 |
Products named: FASENRA, SMARTVEST, AIRSUPRA, DUPIXENT, YUPELRI, NUCALA, Prolastin-C Liquid, TEZSPIRE.
Industry payments across MA — which companies pay providers there.
